Search Results - "Jaakkola, Panu M"

Refine Results
  1. 1

    The regulation, localization, and functions of oxygen-sensing prolyl hydroxylase PHD3 by Jaakkola, Panu M, Rantanen, Krista

    Published in Biological chemistry (01-04-2013)
    “…The prolyl 4-hydroxylase domain protein 3 (PHD3) belongs to 2-oxoglutarate and iron-dependent dioxygenases. Together with the two closest paralogues, PHD1 and…”
    Get more information
    Journal Article
  2. 2

    A three-feature prediction model for metastasis-free survival after surgery of localized clear cell renal cell carcinoma by Mattila, Kalle E., Laajala, Teemu D., Tornberg, Sara V., Kilpeläinen, Tuomas P., Vainio, Paula, Ettala, Otto, Boström, Peter J., Nisen, Harry, Elo, Laura L., Jaakkola, Panu M.

    Published in Scientific reports (21-04-2021)
    “…After surgery of localized renal cell carcinoma, over 20% of the patients will develop distant metastases. Our aim was to develop an easy-to-use prognostic…”
    Get full text
    Journal Article
  3. 3

    Transportable system enabling multiple irradiation studies under simultaneous hypoxia in vitro by Metsälä, Olli, Kreutzer, Joose, Högel, Heidi, Miikkulainen, Petra, Kallio, Pasi, Jaakkola, Panu M

    Published in Radiation oncology (London, England) (13-11-2018)
    “…Cells in solid tumours are variably hypoxic and hence resistant to radiotherapy - the essential role of oxygen in the efficiency of irradiation has been…”
    Get full text
    Journal Article
  4. 4

    Tetraspanin immunoassay for the detection of extracellular vesicles and renal cell carcinoma by Khan, Misba, Islam, Md. Khirul, Rahman, Mafiur, Dhondt, Bert, Quintero, Ileana, Puhka, Maija, Jaakkola, Panu M., Lamminmäki, Urpo, Leivo, Janne

    Published in Nano select (01-09-2024)
    “…Half of patients with renal cell carcinoma (RCC) develop metastases. New and noninvasive biomarkers are needed for the diagnosis of RCC. The study aims to…”
    Get full text
    Journal Article
  5. 5

    Prolyl hydroxylase PHD3 enhances the hypoxic survival and G1 to S transition of carcinoma cells by Högel, Heidi, Rantanen, Krista, Jokilehto, Terhi, Grenman, Reidar, Jaakkola, Panu M

    Published in PloS one (08-11-2011)
    “…Hypoxia restricts cell proliferation and cell cycle progression at the G1/S interface but at least a subpopulation of carcinoma cells can escape the…”
    Get full text
    Journal Article
  6. 6

    p62 degradation by autophagy: Another way for cancer cells to survive under hypoxia by Jaakkola, Panu M., Pursiheimo, Juha-Pekka

    Published in Autophagy (01-04-2009)
    “…Hypoxia is a common feature of advanced solid tumors causing cancer progression and resistance to treatment. Hypoxia activates mitophagy as well as…”
    Get full text
    Journal Article
  7. 7

    Hypoxia-activated Smad3-specific Dephosphorylation by PP2A by Heikkinen, Pekka T, Nummela, Marika, Leivonen, Suvi-Katri, Westermarck, Jukka, Hill, Caroline S, Kähäri, Veli-Matti, Jaakkola, Panu M

    Published in The Journal of biological chemistry (05-02-2010)
    “…The transforming growth factor-β (TGF-β) maintains epithelial homeostasis and suppresses early tumor formation, but paradoxically at later stages of tumor…”
    Get full text
    Journal Article
  8. 8

    Prolyl hydroxylase PHD3 activates oxygen-dependent protein aggregation by Rantanen, Krista, Pursiheimo, Juha, Högel, Heidi, Himanen, Virpi, Metzen, Eric, Jaakkola, Panu M

    Published in Molecular biology of the cell (01-05-2008)
    “…The HIF prolyl hydroxylases (PHDs/EGLNs) are central regulators of the molecular responses to oxygen availability. One isoform, PHD3, is expressed in response…”
    Get full text
    Journal Article
  9. 9

    HIF prolyl hydroxylase PHD3 regulates translational machinery and glucose metabolism in clear cell renal cell carcinoma by Miikkulainen, Petra, Högel, Heidi, Rantanen, Krista, Suomi, Tomi, Kouvonen, Petri, Elo, Laura L, Jaakkola, Panu M

    Published in Cancer & metabolism (04-07-2017)
    “…A key feature of clear cell renal cell carcinoma (ccRCC) is the inactivation of the von Hippel-Lindau tumour suppressor protein (pVHL) that leads to the…”
    Get full text
    Journal Article
  10. 10

    Overexpression and nuclear translocation of hypoxia-inducible factor prolyl hydroxylase PHD2 in head and neck squamous cell carcinoma is associated with tumor aggressiveness by JOKILEHTO, Terhi, RANTANEN, Krista, LUUKKAA, Marjaana, HEIKKINEN, Pekka, GRENMAN, Reidar, MINN, Heikki, KRONQVIST, Pauliina, JAAKKOLA, Panu M

    Published in Clinical cancer research (15-02-2006)
    “…PURPOSE: Hypoxia in tumors is associated with poor prognosis and resistance to treatment. The outcome of hypoxia is largely regulated by the hypoxia-inducible…”
    Get full text
    Journal Article
  11. 11

    Prognostic Factors for Localized Clear Cell Renal Cell Carcinoma and Their Application in Adjuvant Therapy by Mattila, Kalle E, Vainio, Paula, Jaakkola, Panu M

    Published in Cancers (04-01-2022)
    “…Approximately 20% of patients with renal cell carcinoma (RCC) present with primarily metastatic disease and over 30% of patients with localized RCC will…”
    Get full text
    Journal Article
  12. 12

    The role of HIF prolyl hydroxylases in tumour growth by Jokilehto, Terhi, Jaakkola, Panu M.

    Published in Journal of cellular and molecular medicine (01-04-2010)
    “…•  Hypoxia in tumours •  Overview of the oxygen‐sensing mechanisms •  The family of HIF hydroxylases •  Expression of PHDs in normal tissues •  Regulation of…”
    Get full text
    Journal Article
  13. 13

    Hypoxia-inducible factor (HIF)-prolyl hydroxylase 3 (PHD3) maintains high HIF2A mRNA levels in clear cell renal cell carcinoma by Miikkulainen, Petra, Högel, Heidi, Seyednasrollah, Fatemeh, Rantanen, Krista, Elo, Laura L., Jaakkola, Panu M.

    Published in The Journal of biological chemistry (08-03-2019)
    “…Most clear cell renal cell carcinomas (ccRCCs) have inactivation of the von Hippel–Lindau tumor suppressor protein (pVHL), resulting in the accumulation of…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Hypoxia inducible prolyl hydroxylase PHD3 maintains carcinoma cell growth by decreasing the stability of p27 by Högel, Heidi, Miikkulainen, Petra, Bino, Lucia, Jaakkola, Panu M

    Published in Molecular cancer (30-07-2015)
    “…Hypoxia can halt cell cycle progression of several cell types at the G1/S interface. The arrest needs to be overcome by cancer cells. We have previously shown…”
    Get full text
    Journal Article
  16. 16

    Interaction with ErbB4 Promotes Hypoxia-inducible Factor-1α Signaling by Paatero, Ilkka, Jokilammi, Anne, Heikkinen, Pekka T., Iljin, Kristiina, Kallioniemi, Olli-Pekka, Jones, Frank E., Jaakkola, Panu M., Elenius, Klaus

    Published in The Journal of biological chemistry (23-03-2012)
    “…The receptor-tyrosine kinase ErbB4 was identified as a direct regulator of hypoxia-inducible factor-1α (HIF-1α) signaling. Cleaved intracellular domain of…”
    Get full text
    Journal Article
  17. 17

    p62/SQSTM1 regulates cellular oxygen sensing by attenuating PHD3 activity through aggregate sequestration and enhanced degradation by Rantanen, Krista, Pursiheimo, Juha-Pekka, Högel, Heidi, Miikkulainen, Petra, Sundström, Jari, Jaakkola, Panu M

    Published in Journal of cell science (01-03-2013)
    “…The hypoxia-inducible factor (HIF) prolyl hydroxylase PHD3 regulates cellular responses to hypoxia. In normoxia the expression of PHD3 is low and it occurs in…”
    Get full text
    Journal Article
  18. 18

    Hypoxic Conversion of SMAD7 Function from an Inhibitor into a Promoter of Cell Invasion by HEIKKINEN, Pekka T, NUMMELA, Marika, JOKILEHTO, Terhi, GRENMAN, Reidar, KÄHÄRI, Veli-Matti, JAAKKOLA, Panu M

    Published in Cancer research (Chicago, Ill.) (15-07-2010)
    “…Smad7 is an inhibitor of the transforming growth factor-beta-activated signaling pathway. Under well-oxygenated conditions, Smad7 is a potent inhibitor of…”
    Get full text
    Journal Article
  19. 19

    Intra- and extracellular signaling by endothelial neuregulin-1 by Iivanainen, Erika, Paatero, Ilkka, Heikkinen, Satu-Maria, Junttila, Teemu T., Cao, Renhai, Klint, Peter, Jaakkola, Panu M., Cao, Yihai, Elenius, Klaus

    Published in Experimental cell research (01-08-2007)
    “…Suppression of tumor growth by inhibition of ErbB receptor signaling is well documented. However, relatively little is known about the ErbB signaling system in…”
    Get full text
    Journal Article
  20. 20

    Retention of prolyl hydroxylase PHD2 in the cytoplasm prevents PHD2-induced anchorage-independent carcinoma cell growth by Jokilehto, Terhi, Högel, Heidi, Heikkinen, Pekka, Rantanen, Krista, Elenius, Klaus, Sundström, Jari, Jaakkola, Panu M.

    Published in Experimental cell research (15-04-2010)
    “…Cellular oxygen tension is sensed by a family of prolyl hydroxylases (PHD1-3) that regulate the degradation of hypoxia-inducible factors (HIF-1α and -2α). The…”
    Get full text
    Journal Article